Petar Milenkovic

Petar Milenkovic

Research Staff Member

Followers of Petar Milenkovic1000 followers
location of Petar MilenkovicSerbia

Connect with Petar Milenkovic to Send Message

Connect

Connect with Petar Milenkovic to Send Message

Connect
  • Timeline

  • About me

    Radiologist at Ars Medica, Belgrade, Serbia

  • Education

    • Faculty of Medicine, University of Belgrade

      2012 - 2017
      Radiologist Diagnostic Radiology Residency Program
    • Faculty of Medicine, University of Belgrade

      2009 - 2014
      Doctor of Philosophy (PhD) Skeletal Biology
    • Faculty of Medicine, University of Belgrade

      2001 - 2008
      Medical Doctor
    • Dental Technician High School

      1997 - 2001
      Dental Technician
  • Experience

    • Laboratory for Anthropology

      Feb 2003 - now
      Research Staff Member

      Working as independent or team researcher who is fully capable of conducting research, anthropological skeletal analyses, macro and micromorphometry, result analyses, literature analyses, procedures of microCT acquisitions and analyses, writing scientific publications.

    • Clinic of Orthopaedic Surgery and Traumatology, Emergency Centar, Clinical Centre of Serbia

      May 2008 - Nov 2011
      Volunteer

      - Experience gained at Department of Bone and Joint Surgery, Department of Spinal Surgery and Department of Microsurgery.Worked as surgical first assistant in operating hall, hospital ward and emergency room.

    • Faculty of Medicine, University of Belgrade

      Jan 2011 - Apr 2012
      Research Trainee
    • Institute of Oncology and Radiology of Serbia - National Cancer Research Center

      Nov 2011 - Apr 2021

      PSI CRO AG – Synthon Biopharmaceuticals BV, SYD985.003. A single-arm phase II trial to evaluate the safety and efficacy of the antibody-drug conjugate SYD985 in patients with HER2-expressing recurrent, advanced or metastatic endometrial carcinoma. ERGOMED – Zeno Alpha, Inc, ZN-c5-001. A phase 1/2 open label, multicenter study to assess the safety, tolerability, pharmacokinetics, and antitumor activity of ZN-c5 alone and in combination with Palbociclib in subjects with estrogen-receptor positive, human epidermal growth factor receptor-2 negative advanced breast cancer. F. Hoffmann – La Roche, MO39193. Randomized, double blinded, placebo controlled, multicentric study of 3rd phase, for patients with breast metastatic cancer. - Department of Diagnostic Radiology, CT and MRI DivisionConventional radiology, US, CT and MRI diagnostics in the field of body imaging. - Department of Diagnostic Radiology - Department of Diagnostic Radiology - Department of Diagnostic Radiology

      • Clinical Trial - Radiologist

        Jan 2020 - Apr 2021
      • Clinical Trial - Radiologist

        Jan 2020 - Apr 2021
      • Clinical Trial - Radiologist

        Jan 2018 - Apr 2021
      • Radiologist

        Jan 2017 - Apr 2021
      • Radiology Resident

        Nov 2012 - Jan 2017
      • Research Trainee

        Jul 2012 - Apr 2015
      • Medical Doctor

        Apr 2012 - Nov 2012
      • Volunteer

        Nov 2011 - Apr 2012
    • Medicom d.o.o.

      Dec 2012 - now
      Instructor

      Training radiologists to perform everyday work and advanced assignments in Carestream Vue PACS Power Viewer.

    • Institut for oncology and radiology Serbia

      Apr 2015 - Apr 2021
      Research Associate
    • Poliklinika Jatros

      Jun 2020 - Apr 2021
      Radiologist

      US diagnostics in the field of body imaging

    • Sonus Medic

      Jun 2020 - Apr 2021
      Radiologist

      US diagnostics in the field of body imaging and FNAB of thyroid gland

    • MediGroup Srbija

      May 2021 - Mar 2023
      Radiologist

      - Department of Diagnostic RadiologyConventional radiology, US, CT and MRI diagnostics in the field of body imaging.

    • Ars Medica Beograd

      Apr 2023 - now
      Radiologist

      Conventional radiology, US, CT and MRI diagnostics in the field of body imaging.

  • Licenses & Certifications

    • First Certificate in English

      Cambridge English Language Assessment
      Feb 2008